| Mankind Pharma Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 543904 |
NSE Symbol : MANKIND |
P/E(TTM) : 51.96 |
|
ISIN Demat : INE634S01028 |
Div & Yield% : - |
EPS(TTM) : 46.79 |
|
Book Value(₹) : 240.21 |
Market Cap(₹Cr) : 97,396.59 |
Face Value(₹) : 1.00 |
| Particulars | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | 9,264.81 | 8,127.15 | 7,486.22 | 5,523.18 | 4,794.41 |
| Excise Duty | - | - | - | - | - |
| Net Sales | 9,264.81 | 8,127.15 | 7,486.22 | 5,523.18 | 4,794.41 |
| Other Income | 266.64 | 162.78 | 203.81 | 154.50 | 93.85 |
| Stock Adjustments | 25.36 | -267.89 | 365.27 | 254.25 | 44.51 |
| Total Income | 9,556.81 | 8,022.04 | 8,055.30 | 5,931.93 | 4,932.77 |
| EXPENDITURE : | |||||
| Raw Materials | 2,933.66 | 2,576.87 | 2,886.71 | 2,036.42 | 1,617.42 |
| Power and Fuel Cost | 70.43 | 62.00 | 60.36 | 47.16 | 46.49 |
| Other Manufacturing Expenses | 143.14 | 113.62 | 93.57 | 56.71 | 57.73 |
| Selling and Administration Expenses | 1,699.55 | 1,539.07 | 1,378.52 | 905.53 | 696.80 |
| Miscellaneous Expenses | 135.67 | 168.47 | 131.08 | 192.07 | 185.06 |
| Employee Benefit Expenses | 1,982.10 | 1,701.38 | 1,462.76 | 1,167.42 | 991.47 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 2,592.25 | 1,860.65 | 2,042.30 | 1,526.62 | 1,337.79 |
| Interest | 15.08 | 28.23 | 47.54 | 8.23 | 11.10 |
| Gross Profit | 2,577.17 | 1,832.42 | 1,994.76 | 1,518.39 | 1,326.69 |
| Depreciation | 317.61 | 269.58 | 123.33 | 78.19 | 61.77 |
| Profit Before Tax | 2,259.56 | 1,562.84 | 1,871.43 | 1,440.20 | 1,264.92 |
| Current Tax | 416.56 | 291.64 | 429.03 | 346.99 | 341.81 |
| Fringe Benefit tax | - | - | - | - | - |
| Deferred Tax | 19.60 | 22.94 | 52.98 | 8.84 | -35.11 |
| Reported Net Profit | 1,823.41 | 1,248.26 | 1,389.42 | 1,084.37 | 958.23 |
| Extraordinary Items | 108.11 | 29.02 | 62.07 | 30.09 | 18.58 |
| Adjusted Net Profit | 1,715.30 | 1,219.24 | 1,327.35 | 1,054.28 | 939.65 |
| Adjustment below Net Profit | -6.70 | -4.86 | -0.79 | -1.56 | -69.15 |
| Profit/Loss Balance carried down | 7,868.30 | 6,624.90 | 5,236.27 | 3,747.13 | 3,160.50 |
| Statutory Appropriations | - | - | - | - | - |
| Appropriations | - | - | - | - | 302.44 |
| P & L Balance carried down | 9,685.02 | 7,868.30 | 6,624.90 | 4,829.95 | 3,747.13 |
| Dividend | - | - | - | - | - |
| Preference Dividend | - | - | - | - | - |
| Equity Dividend (%) | - | - | - | - | 755.00 |
| Dividend Per Share(Rs) | - | - | - | - | 7.55 |
| Earnings Per Share-Unit Curr | 45.52 | 31.16 | 34.68 | 27.07 | 23.92 |
| Earnings Per Share(Adj)-Unit Curr | 45.52 | - | - | - | - |
| Book Value | 240.24 | 194.31 | 163.27 | 118.18 | 91.15 |
| Book Value(Adj)-Unit Curr | 240.24 | - | - | - | - |